Tailoring Inflammatory Biomarker Assessment in Axial Spondyloarthritis: A Comparative Study of Erythrocyte Sedimentation Rate and C-Reactive Protein Across Disease Profiles
Journal of Personalized Medicine · 25.07.2025 · 15 (8) · 329
DOI: 10.3390/jpm15080329 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Personalized Medicine, online erschienen am 25.07.2025. Verfasst von Rubén Queiro und 6 weiteren Autor:innen. Beteiligte Einrichtung: Rheumatology Division, Hospital Universitario Central de Asturias, 33011 Oviedo, Spain. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Personalized medicine in axial spondyloarthritis (axSpA) requires accurate tools to assess inflammation and tailor disease monitoring. The role of traditional biomarkers such as erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) remains controversial due to limited sensitivity and variability across disease profiles.
Objective
To compare the performance of ESR and CRP in different clinical scenarios of axSpA, including disease activity, functional impact, severity, disease duration, and exposure to biologic therapy.
Methods
We conducted a cross-sectional analysis of 330 patients with axSpA. Correlations among ESR, CRP, and composite disease indices were evaluated. The discriminatory capacity of each biomarker for relevant clinical thresholds was analyzed using ROC curves and optimal cut-offs identified by the Youden index.
Results
ESR showed broader correlations with disease impact and activity scores than CRP. While both markers had low sensitivity overall, they were highly specific for identifying patients with very high disease activity in select scenarios. ESR ≥ 8.5 mm/h and CRP ≥ 1.88 mg/dL were strongly discriminatory in patients not exposed to biologics. CRP ≥ 0.56 mg/dL showed good performance in early disease.
Conclusions
Both ESR and CRP provide complementary insights into disease activity in axSpA. ESR may offer a broader reflection of disease burden beyond inflammation. These results support a more personalized biomarker strategy in real-world axSpA management, adapted to patient profile and treatment context.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Rheumatology Division, Hospital Universitario Central de Asturias, 33011 Oviedo, Spain.
- Department of Medicine, Oviedo University School of Medicine, 33011 Oviedo, Spain.
- Translational Immunology Division, Health Research Institute of the Principality of Asturias (ISPA), 33011 Oviedo, Spain.
ORCID-Profile: Rubén Queiro
Zitieren
APA
Queiro, R., Alonso, S., Burger, S., Pardo, E., Braña, I., Loredo, M., & Alperi, M. (2025). Tailoring Inflammatory Biomarker Assessment in Axial Spondyloarthritis: A Comparative Study of Erythrocyte Sedimentation Rate and C-Reactive Protein Across Disease Profiles. Journal of Personalized Medicine, 15(8), 329. https://doi.org/10.3390/jpm15080329
Vancouver
Queiro R, Alonso S, Burger S, Pardo E, Braña I, Loredo M, et al. Tailoring Inflammatory Biomarker Assessment in Axial Spondyloarthritis: A Comparative Study of Erythrocyte Sedimentation Rate and C-Reactive Protein Across Disease Profiles. Journal of Personalized Medicine. 2025;15(8):329. doi:10.3390/jpm15080329
BibTeX
@article{Queiro2025,
author = {Queiro, Rubén and Alonso, Sara and Burger, Stefanie and Pardo, Estefanía and Braña, Ignacio and Loredo, Marta and Alperi, Mercedes},
title = {Tailoring Inflammatory Biomarker Assessment in Axial Spondyloarthritis: A Comparative Study of Erythrocyte Sedimentation Rate and C-Reactive Protein Across Disease Profiles},
journal = {Journal of Personalized Medicine},
year = {2025},
volume = {15},
number = {8},
pages = {329},
doi = {10.3390/jpm15080329}
}
EUVIMED